This post was originally published on this site
Keefe, Bruyette & Woods downgraded Jefferies Financial Group (NYSE:JEF) to Market Perform from Outperform ahead of the upcoming Q4 results announcement on Jan 9, 2023. Shares were down more than 4% intra-day.
Oppenheimer downgraded Fate Therapeutics (NASDAQ:FATE) to Perform from Outperform as part of a broader downgrade on the NK-cell therapy space. Shares fell more than 10% intra-day today.
Oppenheimer downgraded Celularity (NASDAQ:CELU) to Perform from Outperform. Shares were trading more than 8% lower intra-day today.
Want to get this news first? Upgrade to InvestingPro for real-time market coverage.
